CM Life Sciences, Inc. (CMLFU) Prices Upsized $385M SPAC IPO
CM Life Sciences, Inc. (CMLFU), announced the pricing of their upsized $385 million IPO this evening and the units are expected to begin trading tomorrow, Wednesday, September 2nd, under the symbol Nasdaq: CMLFU.
CM Life Sciences intends to focus on companies in the life sciences sector and will be led by Keith A. Meister, as Chairman, and Eli Casdin, as Chief Executive Officer and Director.
Total SPAC deal count for 2020 year-to-date is now 82 with $33.53 billion in gross proceeds raised. The offering is anticipated to close on Friday, September 5, 2020.
Jefferies LLC is serving as the sole book runner for the offering. White & Case LLP and Skadden, Arps, Slate, Meagher & Flom LLP, were Issuer’s Counsel and Underwriter’s Counsel, respectively. WithumSmith+Brown, PC, acted as auditor. Continental Stock Transfer & Trust Company is acting as trustee.